Frequently Asked Questions
Contrast and Imaging Agents in Interventional X-Ray Market will be worth USD 3.46 billion by 2030
Contrast and Imaging Agents in Interventional X-Ray Market growth rate is 5.13% during the forecast period.
Increasing Prevalence of Chronic Diseases, Advancements in Imaging Technologies, Growing Investment in Research and Development are the growth drivers of the Europe Contrast and Imaging Agents in Interventional X-Ray Market.
Type, application and end-user are the factors on which the Europe Contrast and Imaging Agents in Interventional X-Ray Market research is based.
Qaelum NV announced a strategic partnership with Ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of Ulrich Medical to support the needs of hospitals and imaging networks & Guerbet and Bracco Imaging announced a Europe collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent are the latest developments in the Europe Contrast and Imaging Agents in Interventional X-Ray Market.
